Search research articles
Contact Us
Filters
Showing results (171-180 of 364) with videos related to
Page
of 37
Sort By:
Applied Clinical Informatics
|
June 2, 2021
Clinician Perceptions on the Use of Free-Text Communication Orders
Swaminathan Kandaswamy, Zoe Pruitt, Sadaf Kazi, et al.
The American Journal of Surgical Pathology
|
March 19, 2015
Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases
Rish K Pai, Thomas P Plesec, Fadi W Abdul-Karim, et al.
International Journal of Cardiology
|
March 19, 2021
Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy
Nadya Al-Wakeel-Marquard, Franziska Seidel, Christopher Herbst, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
July 10, 2012
Approach to the management of slipped capital femoral epiphysis and primary hyperparathyroidism
Tarik El Scheich, Jan Marquard, Bettina Westhoff, et al.
Neurogenetics
|
September 21, 2013
Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy
Tobias Geis, Klaus Marquard, Tanja Rödl, et al.
Applied Clinical Informatics
|
July 21, 2016
Usability Testing of Two Ambulatory EHR Navigators
Gretchen Hultman, Jenna Marquard, Elliot Arsoniadis, et al.
Gynecologic Oncology
|
July 27, 2015
Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer
Haider Mahdi, Allison Gockley, Katherine Esselen, et al.
Environmental Management
|
September 20, 2021
Recycling Nutrients and Reducing Carbon Emissions in the Baltic Sea Region-Sustainable or Economically Infeasible?
Gustav Marquard Callesen, Søren Marcus Pedersen, Johannes Carolus, et al.
The Lancet. Diabetes & Endocrinology
|
February 4, 2023
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
Lori M Laffel, Thomas Danne, Georgeanna J Klingensmith, et al.
British Journal of Clinical Pharmacology
|
May 20, 2025
Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10-17 years with type 2 diabetes mellitus
Juliane Rascher, Shen Cheng, Curtis Johnston, et al.
Page
of 37
Search research articles
Search
Showing results (171-180 of 364) with videos related to
Sort By:
Page
of 37
Applied Clinical Informatics
|
June 2, 2021
Clinician Perceptions on the Use of Free-Text Communication Orders
Swaminathan Kandaswamy, Zoe Pruitt, Sadaf Kazi, et al.
The American Journal of Surgical Pathology
|
March 19, 2015
Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases
Rish K Pai, Thomas P Plesec, Fadi W Abdul-Karim, et al.
International Journal of Cardiology
|
March 19, 2021
Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy
Nadya Al-Wakeel-Marquard, Franziska Seidel, Christopher Herbst, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
July 10, 2012
Approach to the management of slipped capital femoral epiphysis and primary hyperparathyroidism
Tarik El Scheich, Jan Marquard, Bettina Westhoff, et al.
Neurogenetics
|
September 21, 2013
Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy
Tobias Geis, Klaus Marquard, Tanja Rödl, et al.
Applied Clinical Informatics
|
July 21, 2016
Usability Testing of Two Ambulatory EHR Navigators
Gretchen Hultman, Jenna Marquard, Elliot Arsoniadis, et al.
Gynecologic Oncology
|
July 27, 2015
Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer
Haider Mahdi, Allison Gockley, Katherine Esselen, et al.
Environmental Management
|
September 20, 2021
Recycling Nutrients and Reducing Carbon Emissions in the Baltic Sea Region-Sustainable or Economically Infeasible?
Gustav Marquard Callesen, Søren Marcus Pedersen, Johannes Carolus, et al.
The Lancet. Diabetes & Endocrinology
|
February 4, 2023
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
Lori M Laffel, Thomas Danne, Georgeanna J Klingensmith, et al.
British Journal of Clinical Pharmacology
|
May 20, 2025
Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10-17 years with type 2 diabetes mellitus
Juliane Rascher, Shen Cheng, Curtis Johnston, et al.
Page
of 37